Working across the life sciences translation pathway 

Apex Science works alongside organisations bringing life sciences research from discovery to clinical application. Oncology is the deepest area of expertise, and the same approach applies across therapeutics, diagnostics and health technology.

This includes partnering with medical research charities to clarify research priorities and guide research investment decisions, and supporting early-stage life sciences companies preparing programs for funding, partnership, and clinical trials.

Across this pathway, the focus is consistent: ensuring scientific, translational, and funding decisions are grounded in biological reality and aligned with a credible path to patient impact.

Support is typically provided at key transition points in the translation pathway, including:

• defining research priorities and investment focus

• preparing programs for grant, philanthropic, or investor funding

• assessing translational readiness of research programs

• planning translational development and clinical trial pathways

• strengthening scientific input to board and executive decisions

These moments often shape the long-term direction of research programs, portfolios, and companies.

Work is collaborative, science-led, and tailored to the organisation and decision context.

Apex Science works directly with clinicians, researchers, executives, founders, and funders, often across multiple organisations, to connect scientific evidence, translational planning, and funding strategy.

The goal is clarity, alignment and confidence in the decisions being made.

Engagements usually begin with a small number of focused conversations to clarify the scientific, translational, and strategic context of the decision.

From there, work may include:

• reviewing research programs or funding proposals

• mapping translational pathways and development sequencing

• clarifying milestones and decision points

• preparing programs for funding, partnership, or clinical trials

• providing ongoing scientific advisory support where needed

Engagements are typically fixed-scope, founder-led, and designed to support real decisions within defined timeframes.